Proteomic Analysis of Bladder Cancer Indicates Prx-I as a Key Molecule in BI-TK/GCV Treatment System
Figure 2
Bioinformatic analysis of differentially expressed proteins after treatment with BI-TK/GCV.
PANTHER classification of proteins based on (A) Biological process and (B) molecular function. (C) Interplaying network of proteins with abundance change generated by Ingenuity pathway analysis (IPA). The network implied the connection of Prx-I and NF-κB complex.